PCS-2023 > 3 > 3E > 3E0 > 3E01 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E01 | Introduction, Subcutaneous Tissue | |
3E010 | Open | |
3E0102 | Anti-infective | |
3E0102A | Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach | |
3E013 | Percutaneous | |
3E0130 | Antineoplastic | |
3E01305 | Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach | |
3E0130M | Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach | |
3E0132 | Anti-infective | |
3E01328 | Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach | |
3E01329 | Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach | |
3E0132A | Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach | |
3E0133 | Anti-inflammatory | |
3E0133Z | Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach | |
3E0136 | Nutritional Substance | |
3E0136Z | Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach | |
3E0137 | Electrolytic and Water Balance Substance | |
3E0137Z | Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach | |
3E013B | Anesthetic Agent | |
3E013BZ | Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach | |
3E013H | Radioactive Substance | |
3E013HZ | Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach | |
3E013K | Other Diagnostic Substance | |
3E013KZ | Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach | |
3E013N | Analgesics, Hypnotics, Sedatives | |
3E013NZ | Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach | |
3E013T | Destructive Agent | |
3E013TZ | Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach | |
3E0134 | Serum, Toxoid and Vaccine | |
3E01340 | Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach | |
3E0134Z | Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach | |
3E013G | Other Therapeutic Substance | |
3E013GC | Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach | |
3E013V | Hormone | |
3E013VG | Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach | |
3E013VJ | Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |